...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Clinical trials query results

KBC can you perhaps understand why ZEN-3694 et al does not come up when searched under

https://health-products.canada.ca/ctdb-bdec/index-eng.jsp

 

Koo

Share
New Message
Please login to post a reply